Content and Format of an Investigational New Drug (IND ...

FDA may terminate an IND based on deficiencies in the IND or in the conduct of an investigation under the IND. If an IND is terminated by the FDA, the sponsor shall end all clinical studies being conducted under the IND and shall recall or otherwise provide for the disposition of all unused supplies of the investigational drug. ................
................